Osteoarthritis and Cartilage

Papers
(The H4-Index of Osteoarthritis and Cartilage is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Macrophages regulate the progression of osteoarthritis245
Epidemiology of osteoarthritis214
Osteoarthritis year in review 2021: epidemiology & therapy171
The role of macrophages in osteoarthritis and cartilage repair144
Osteoarthritis year in review 2020: biology108
Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2/NF-κB axis102
Trends in incidence and prevalence of osteoarthritis in the United Kingdom: findings from the Clinical Practice Research Datalink (CPRD)100
The burden of OA-health services and economics97
Roles of NLRP3 inflammasome in intervertebral disc degeneration89
Osteoarthritis year in review 2020: epidemiology & therapy80
Identifying effector molecules, cells, and cytokines of innate immunity in OA67
The causal role of gut microbiota in development of osteoarthritis66
Osteoarthritis year in review 2021: biology65
Single-cell RNA-seq analysis identifies unique chondrocyte subsets and reveals involvement of ferroptosis in human intervertebral disc degeneration65
The innate immune response as a mediator of osteoarthritis pain62
How does hip osteoarthritis differ from knee osteoarthritis?58
The compartmental distribution of knee osteoarthritis – a systematic review and meta-analysis55
Osteoarthritis-associated basic calcium phosphate crystals alter immune cell metabolism and promote M1 macrophage polarization54
The role of structure and function changes of sensory nervous system in intervertebral disc-related low back pain54
Genetics of osteoarthritis54
Osteoarthritis year in review: genetics, genomics, epigenetics49
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis47
A lifespan approach to osteoarthritis prevention46
Immediate outcomes following the GLA:D® program in Denmark, Canada and Australia. A longitudinal analysis including 28,370 patients with symptomatic knee or hip osteoarthritis46
Fundamentals of OA. An initiative of Osteoarthritis and Cartilage. Obesity and metabolic factors in OA45
Osteoarthritis year in review 2020: rehabilitation and outcomes44
The effects of TNF-alpha inhibition on cartilage: a systematic review of preclinical studies43
Association between knee inflammation and knee pain in patients with knee osteoarthritis: a systematic review43
Melatonin activates autophagy via the NF-κB signaling pathway to prevent extracellular matrix degeneration in intervertebral disc42
MFN2 contributes to metabolic disorders and inflammation in the aging of rat chondrocytes and osteoarthritis42
tRNA-derived fragments (tRFs) regulate post-transcriptional gene expression via AGO-dependent mechanism in IL-1β stimulated chondrocytes41
Systematic review and meta-analysis of the prevalence of neuropathic-like pain and/or pain sensitization in people with knee and hip osteoarthritis40
Factors secreted from dental pulp stem cells show multifaceted benefits for treating experimental temporomandibular joint osteoarthritis40
Sequencing identifies a distinct signature of circulating microRNAs in early radiographic knee osteoarthritis39
Are education, exercise and diet interventions a cost-effective treatment to manage hip and knee osteoarthritis? A systematic review39
The role of stromal cell-derived factor 1 on cartilage development and disease39
Activation of TRPV4 by mechanical, osmotic or pharmaceutical stimulation is anti-inflammatory blocking IL-1β mediated articular cartilage matrix destruction38
Targeting STING attenuates ROS induced intervertebral disc degeneration37
0.031943082809448